Acta Med. 2011, 54: 111-116
https://doi.org/10.14712/18059694.2016.31
Analysis of D1853N ATM Polymorphism in Radiosensitive Patients with Cervical Carcinoma
References
1. CN, Overgaard J, Alsner J. ATM sequence variants and risk of radiation- induced subcutaneous fibrosis after post-mastectomy radiotherapy. Int J Radiat Oncol Biol Phys 2006; 64:776–83.
<https://doi.org/10.1016/j.ijrobp.2005.09.014>
2. S, Falconer A, Edwards SM, et al. ATM polymorphisms as risk factors for prostate cancer development. Brit J Cancer 2004; 91:783–7.
<https://doi.org/10.1038/sj.bjc.6602007>
<PubMed>
3. S, Romestaing P, Moullan N, et al. ATM haplotypes and cellular response to DNA damage: Association with breast cancer risk and clinical radiosensitivity. Cancer Res 2003; 63:8717–25.
4. JL, Teraoka S, Haile RW, et al. Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. Hum Mutat 2003; 542–50.
<https://doi.org/10.1002/humu.10206>
5. , P., Haiman CA, Gilad S, et al. The relationship between twenty missense ATM variants and breast cancer risk: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2003; 12:733–8.
6. F, Rasio D, Kitada S, et al. ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res 1999; 59:24–7.
7. Cavaciuti E., Lauge A., Janin N., et al. Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families. Genes C
8. JA, Stock RG, Lehner S, Atencio DA, Bernstein JL, Stone NN. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. Int J Radiat Oncol Biol Phys 2005; 61:196–202.
<https://doi.org/10.1016/j.ijrobp.2004.09.031>
9. D, Wang Y, Qin J, Elledge SJ. Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks. Science 1999; 286:1162–6.
<https://doi.org/10.1126/science.286.5442.1162>
10. SL, Weischer M, Allin KH, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. Risk of cancer by ATM missense mutations in the general population. J Clin Oncol 2008; 26:3057–62.
<https://doi.org/10.1200/JCO.2007.14.6613>
11. T, Bendix R, Bremer M, et al. Spectrum of ATM gene mutations in a hospitalbased series of unselected breast cancer patients. Cancer Res 2001; 61:7608–15.
12. T, Wei S, Ziv Y, et al. Localization of an ataxia-telangiectasia locus to a 3-cM interval on chromosome 11q23: Linkage analysis of 111 families by an international consortium. Am J Human Genet 1991; 49:1263–79.
13. LB, Pan XM, Sun H, et al. The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis. J Exp Clin Cancer Res 2010; 29:117.
<https://doi.org/10.1186/1756-9966-29-117>
<PubMed>
14. P, Bravo T, Blanco R, et al. Association of common ATM variants with familial breast cancer in a Southern American population. BMC Cancer 2008; 8:117.
<https://doi.org/10.1186/1471-2407-8-117>
<PubMed>
15. K, Rapakko K, Karppinen SM, Erkko H, Nieminen P, Winqvist R. Association of common ATM polymorphism with bilateral breast cancer. Int J Cancer 2005; 116:69–72.
<https://doi.org/10.1002/ijc.20996>
16. JH, Kim H, Lee KY, et al. Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk. Hum Mol Genet 2006; 15:1181–6.
<https://doi.org/10.1093/hmg/ddl033>
17. D, Suzuki H, Liu B, et al. DNA repair gene polymorphisms and risk of pancreatic cancer. Clin Cancer Res 2009; 15:740–6.
<https://doi.org/10.1158/1078-0432.CCR-08-1607>
<PubMed>
18. P, Chappuis PO, Vaudan G, et al. A polymorphism in the ATM gene modulates the penetrance of hereditary non-polyposis colorectal cancer. Int J Cancer 2000; 88:928–31.
<https://doi.org/10.1002/1097-0215(20001215)88:6<928::AID-IJC14>3.0.CO;2-P>
19. P, Vaudan G, Chappuis P, Sappino AP. PCR-mediated detection of a polymorphism in the ATM gene. Moll Cell Probes 1999; 13:67–9.
<https://doi.org/10.1006/mcpr.1998.0219>
20. N, Platzer M, Rosenthal A, et al. Characterization of ATM gene mutations in 66 ataxia telangiectasia families. Hum Mol Genet 1999; 8:69–79.
<https://doi.org/10.1093/hmg/8.1.69>
21. K, Bar-Shira A, Gilad S, et al. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268:1749–53.
<https://doi.org/10.1126/science.7792600>
22. Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003; 3:155–68.
<https://doi.org/10.1038/nrc1011>
23. DL, Garcia-Closas M, Pineda MA, et al. The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer. Hum Mutat 2006; 27: 538–44.
<https://doi.org/10.1002/humu.20323>
<PubMed>
24. M, Reitnauer PJ, Morrell D, Chase CL. Breast and other cancers in families with ataxia-telangiectasia. New Engl J Med 1987; 316:1289–94.
<https://doi.org/10.1056/NEJM198705213162101>
25. SN, Telatar M, Becker-Catania S, et al. Splicing defects in the ataxiatelangiectasia gene, ATM: Underlying mutations and consequences. Am J Hum Genet 1999; 64:1617–31.
<https://doi.org/10.1086/302418>
<PubMed>
26. YR, Roxas A, Kroiss R, et al. Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res 2003; 63:3325–33.
27. A, Vávrová J, Pejchal J, Řezáčová M. Ataxia-telangiectasia mutated kinase (ATM) as a central regulator of radiation-induced DNA damage response. Acta Medica 2010; 53:13–7.
28. J, Jansen L, Kilpivaara O, et al. ATM variants and cancer risk in breast cancer patients from Southern Finland. BMC Cancer 2006; 6:209.
<https://doi.org/10.1186/1471-2407-6-209>
<PubMed>
29. N, Bay J, Pernin D, et al. Loss of heterozygosity at the ATM locus in colorectal carcinoma. Oncol Rep 1999; 6:655–8.
30. I, Luo L, Dyer MJS, et al. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nature Genet 1997; 17:96–9.
<https://doi.org/10.1038/ng0997-96>
31. L, Jia G, Li WM, et al. Alteration of the ATM gene occurs in gastric cancer cell lines and primary tumors associated with cellular response to DNA damage. Mutat Res 2004; 557:41–51.
<https://doi.org/10.1016/j.mrgentox.2003.09.012>
